OH
PBYI icon

Orbis Holdings’s Puma Biotechnology PBYI Stock Holding History

Orbis Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.44M Sell
43,854
-7,827
-15% -$614K 0.03% 71
2015
Q3 		$3.89M Sell
51,681
-9,398
-15% -$889K 0.03% 71
2015
Q2 		$7.13M Sell
61,079
-113,187
-65% -$20.5M 0.05% 71
2015
Q1 		$41.1M Sell
174,266
-56,367
-24% -$12M 0.33% 44
2014
Q4 		$43.7M Buy
230,633
+13,371
+6% +$2.97M 0.33% 45
2014
Q3 		$51.8M Buy
+217,262
New +$44.6M 0.41% 45

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Orbis Holdings's PBYI Position: Q4 2015 in Review

Orbis Holdings reduced its Puma Biotechnology (PBYI) stake by 15% in Q4 2015, selling an estimated $614K and leaving 43,854 shares worth $3.44M. The position accounts for 0.03% of the portfolio, ranked #71.

Orbis Holdings first reported a position in PBYI in Q3 2014 and has held it in 6 quarters since. The position peaked at $51.8M in Q3 2014. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

  • Orbis Holdings held 43,854 shares of Puma Biotechnology worth $3.44M as of Q4 2015.
  • Orbis Holdings sold 7,827 Puma Biotechnology shares in Q4 2015, an estimated $614K.
  • Puma Biotechnology made up 0.03% of Orbis Holdings's portfolio in Q4 2015, its #71 holding.
  • Orbis Holdings first reported a position in Puma Biotechnology in Q3 2014 and has held it in 6 quarters since.
  • Orbis Holdings's Puma Biotechnology position peaked at $51.8M in Q3 2014.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.